N. Willmott
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 9
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 10
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Toxicology top 5%
- Oncology top 10%
- Cancer Treatment and Pharmacology 10
-
- Chemotherapy-induced cardiotoxicity and mitigation 9
-
- Protein Interaction Studies and Fluorescence Analysis 6
-
- Lanthanide and Transition Metal Complexes 6
-
- Cancer Research and Treatments 6
- Co-authors
- Jeffrey L. CummingsAlastair J. FlorenceJohn F. SmythCS McArdleDJ KerrLorraine AndersonAlan RogersonJ. H. McKillop
- Journals
- British Journal of Cancer (9 papers)Biochemical Pharmacology (7 papers)Journal of Pharmacy and Pharmacology (4 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
N. Willmott
62 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Pharmaceutical Science 297
- Biomaterials 221
- Hepatology 125
- Toxicology 51
- Oncology 391
Countries citing papers authored by N. Willmott
This map shows the geographic impact of N. Willmott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Willmott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Willmott more than expected).
Fields of papers citing papers by N. Willmott
This network shows the impact of papers produced by N. Willmott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Willmott. The network helps show where N. Willmott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N. Willmott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 0 | |
| 2 | 2020 | 0 | |
| 3 | 1997 | 48 | |
| 4 | 1995 | 10 | |
| 5 | 1993 | 6 | |
| 6 | 1992 | 5 | |
| 7 | 1992 | 40 | |
| 8 | 1992 | 6 | |
| 9 | 1992 | 36 | |
| 10 | 1991 | 8 | |
| 11 | 1991 | 13 | |
| 12 | 1991 | 10 | |
| 13 | 1991 | 12 | |
| 14 | 1991 | 2 | |
| 15 | 1991 | 128 | |
| 16 | 1990 | 17 | |
| 17 | 1988 | 19 | |
| 18 | 1987 | 16 | |
| 19 | 1987 | 19 | |
| 20 | Comparative studies of the metastatic potential of three transplantable rat mammary carcinomas of spontaneous origin. | 1979 | 5 |
About N. Willmott
N. Willmott is a scholar working on Pharmaceutical Science, Hepatology, Biotechnology, Biomaterials and Oncology, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Cancer Treatment and Pharmacology (10 papers), Advanced Drug Delivery Systems (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Protein Interaction Studies and Fluorescence Analysis (6 papers), Lanthanide and Transition Metal Complexes (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Pharmaceutical Science (297 citations), Biomaterials (221 citations), Hepatology (125 citations), Toxicology (51 citations) and Oncology (391 citations). N. Willmott has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Jeffrey L. Cummings, Alastair J. Florence, John F. Smyth, CS McArdle, DJ Kerr, Lorraine Anderson, Alan Rogerson, J. H. McKillop, Joseph C. Anderson and Yan Chen. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, Journal of Pharmacy and Pharmacology, Nuclear Medicine Communications and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.